DR . Sudeep Garg

Dr Sudeep Garg is one of the leading Oncologists in Lucknow city and currently “Head of Department of Surgical Oncology” at Vivekanand polyclinic and institute of medical sciences ,Lucknow. He has been in the field of Surgical oncologysince 2012 (10 yrs exp) . He did MCh in Surgical Oncology from India’s Most Premier Institute- “King George’s Medical

University Lucknow, UP” This Institute is amongst the best Medical Institutes in South Asian . The area of expertise includes

advanced Open & Laparoscopic Oncosurgeries such as Wertheim’s Radical Hysterectomy, Radical Nephrectomy/Radical

Cystectomy, Open & Lap Abdominoperineal resection, Total Colectomy, Pelvic Exenterations, Open & Lap Oesophagectomy.

Also competent in Hepatobiliary cancer Surgeries specially Gall bladder cancer.

Additionally, a vast experience in Breast Cancer Surgery including Oncoplastic Breast surgeries such as Breast reconstruction

University Lucknow, UP” This Institute is amongst the best Medical Institutes in South Asian . The area of expertise includes

advanced Open & Laparoscopic Oncosurgeries such as Wertheim’s Radical Hysterectomy, Radical Nephrectomy/Radical

Cystectomy, Open & Lap Abdominoperineal resection, Total Colectomy, Pelvic Exenterations, Open & Lap Oesophagectomy.

Also competent in Hepatobiliary cancer Surgeries specially Gall bladder cancer.

Additionally, a vast experience in Breast Cancer Surgery including Oncoplastic Breast surgeries such as Breast reconstruction

Publications

Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival ?

November 2020 Annals of Hepato-Biliary-Pancreatic Surgery 24(4):460-468DOI:10.14701/ahbps.2020.24.4.460

Validation of the Brandwein Gensler Risk Model in Patients of Oral Cavity Squamous Cell Carcinoma in North India

September 2020 Head and Neck Pathology 14(9828) :10.1007/s12105-019-01082-6

Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: An Institutional Experience

December 2019 Indian Journal of Gynecologic Oncology 17(4) DOI:10.1007/s40944-019-0322-1

Role of serum HE4 as a prognostic marker in carcinoma of the ovary

July 2019 Indian Journal of Cancer 56(3):216-221 DOI:10.4103/ijc.IJC_305_18

Virilizing Steroid Cell Tumor of the Ovary: Successful Surgical Management of an Enigma

May 2019 Indian Journal of Surgical Oncology 11(11)\ DOI:10.1007/s13193-019-00931-8

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: An institutional experience.

May 2019 Journal of Clinical Oncology 37(15_suppl):e17044-e17044 DOI:10.1200/JCO.2019.37.15_suppl.e17044

Germ Cell Tumor Ovary: an Institutional Experience of Treatment and Survival Outcomes

April 2018 Indian Journal of Surgical Oncology 9(2) DOI:10.1007/s13193-018-0742-x

Prognosis of carcinoma breast based on intrinsic subtypes – a single centre study

March 2017 Breast (Edinburgh, Scotland) 32(1):S95 DOI:10.1016/S0960-9776(17)30305-3

Awards and Honors

➢ Presented poster in IASO, NATCON 2016 ,Jodhpur 2018

➢ Presented video on platysmal myocutaneous flap in IASO NATCON 2016 ,Jodhpur, 2018

➢ Presented paper on ‘Nasolabial flap reconstruction in early stage Ca oral cavity’ in 2017

➢ 5th Congress Of Asian Society Of Head & Neck Oncology Bali, Indonesia2017

➢ Presented poster in IASO, NATCON 2016 ,Jodhpur2016

➢ Presented video on platysmal myocutaneous flap in IASO NATCON 2016 ,Jodhpur, 2016

➢ Presented paper & poster in ISO UP Chapter 2010

➢ Presented posters & papers in Trauma 2009 AIIMS ,New Delhi

➢ Achieved best video presentation award in NATCON 2016

➢ Free membership of IASO as an award